Allarity Therapeutics, Inc.

NasdaqCM:ALLR Stock Report

Market Cap: US$451.1k

Allarity Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of ALLR?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders90.00291%
Private Companies2760.0893%
Institutions2,9520.956%
General Public305,70799%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 5853.8%.


Top Shareholders

Top 9 shareholders own 1.05% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
0.61%
Two Sigma Securities, LLC, Asset Management Arm
1,877US$2.7k198%no data
0.24%
Virtu Financial LLC, Asset Management Arm
750US$1.1k-41.8%no data
0.089%
Tower Research Capital LLC
276US$403.0-1.08%no data
0.089%
Geode Capital Management, LLC
275US$401.53.77%no data
0.016%
Avanza Fonder AB
49US$71.50%no data
0.0016%
Steen Knudsen
5US$7.3400%no data
0.00097%
Thomas Jensen
3US$4.40%no data
0.00032%
Marie Foegh
1US$1.4-75%no data
0.00032%
Wells Fargo & Company, Private Banking and Investment Banking Arm
1US$1.40%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.